Introduction
Corticosteroids administered during pregnancy or maternal Cushing's syndrome can cause suppression of fetal adrenal glands (1, 2, 3, 4, 5, 6, 7) . Maternal use of corticosteroids is needed in case of fetal congenital adrenal hyperplasia, as well as in maternal diseases such as idiopathic thrombocytopenic purpura (ITP), Crohn's disease, systemic lupus erythematosus, Addison's disease and rheumatological problems (3, 8, 9 ). Short-term corticosteroid treatment is given in case of preterm labor to enhance fetal lung maturation (8) . When using corticosteroids during pregnancy, the choice of preparation type and dose is of utmost importance -steroids crossing the placenta freely should be given if the target is fetus, while those passing across the placenta should be used in smaller amount if maternal disorders are being treated (1) .
In this article, adrenal suppression pattern in a newborn exposed to long-term maternal methylprednisolone therapy were presented with special emphasis on short term follow up of such infants.
Case
A 20-minute-old newborn, whose mother used 64 mg methylprednisolone per day during her pregnancy due to ITP, was hospitalized for follow-up. Pregnancy duration was 39 weeks. The neonate was 2680 grams (3-10 th percentile) at birth with head circumference of 36 cm (75-90 th percentile) and height of 50 cm (25-30 th percentile). Whole blood examination showed hemoglobin level of 19.1 g/dL, leukocyte count of 10 530/mm 3 , and platelet count of 10 000/mm 3 . Biochemistry ABSTRACT During pregnancy, steroids are usually used in maternal diseases such as adrenal failure or other autoimmune diseases, e.g. idiopathic thrombocytopenic purpura (ITP), Crohn's disease, systemic lupus erythematosus, dermatomyositis, scleroderma, Addison's disease and hyperemesis gravidarum, HELLP syndrome. Endogenous or exogenous maternal steroids are metabolized by the placental enzyme 11 beta-hydroxy steroid dehydrogenase type 2. Prednisolone and methylprednisolone are highly sensitive to this enzyme, while dexamethasone and betamethasone are less well metabolized. Steroids which can cross the placental barrier are administered in cases like fetal lupus, congenital adrenal hyperplasia and for enhancement of fetal lung maturation, whereas steroids used in maternal diseases are usually the ones with low affinity to the placenta; however, in case of long-term use or in high doses, placental enzyme saturation occurs and thus, resulting in fetal adrenal suppression. Antenatal steroids can lead to low birth weight, as observed in our patient. Here, we report a case with fetal adrenal suppression due to maternal methylprednisolone use presenting with early hypoglycaemia and late hyponatremia in neonatal period and requiring three-month replacement therapy. K Ke ey y w wo or rd ds s: : Pregnancy, exsogenous corticosteroids, fetal adrenal suppression C Co on nf fl li ic ct t o of f i in nt te er re es st t: : None Table 1 . These results showed that the patient was relived from adrenal suppression.
Discussion
Corticosteroids are given during pregnancy if needed in maternal diseases or other pregnancy-related problems as well as to treat certain fetal diseases; in the latter cases, corticosteroids capable of crossing the placenta are administered to the mother (5, 6, 7, 8, 9) .
As side effects to the mother, steroids used during pregnancy can cause weight gain, dyslipidemia, hypertension, cushingoid appearance, acne, hypertrichosis, psychological problems (8) . Corticosteroids are metabolized in the placenta by the help of the enzyme 11-β-hydroxylase steroid dehydrogenase-2 (10). Cortisol, a physiologic steroid, is metabolized to cortisone. Similarly, synthetic glucocorticosteroids are metabolized to inactive metabolites in the placenta. Prednisolone-related drugs are mostly degraded to inactive forms by the placental enzymes and, approximately 10% of the total amount will ultimately reach the fetus and among this whole, about 33% of betamethasone and 50% of dexamethasone will enter the fetal circulation (11, 12) . Besides this, when taken in high doses and for long period of time, prednisolone and methylprednisolone themselves can saturate the placental enzymes and, as a result, large amount of corticosteroids can cross the placental barrier causing significant suppression of the fetal glands, as observed in our case (5) . Fetal adrenal suppression develops approximately within 14 days after maternal steroid use, therefore, the neonate may be born with ACTH suppression (5). Adrenal gland insufficiency becomes prominent on postnatal day 3 -the neonate develops hyponatremia, hypoglycemia and hypotension. Since there is central adrenal insufficiency due to long-term steroid effect, potassium level is within normal limits, or even low. It is well known that long-term steroid use can cause low birth weight, as in our case (12) .
In our patient, high-dose methylprednisolone saturated the placental enzymes, the steroids crossed the placenta more significantly and in higher amounts, thus, causing fetal adrenal suppression. On the fourth day, cortisol level was within normal ranges, but we consider that there might be an interference between crossed maternal steroids, their metabolites and fetal cortisol. Since on the 10 th day ACTH and cortisol levels were found to be suppressed, this shows the importance of measuring cortisol and ACTH levels during the second week.
Thus, steroids crossing the placenta in small amount should be preferred during pregnancy in case of maternal disorders necessitating steroid use. The newborns should be followed postnatally. On postnatal day 4, basal cortisol and ACTH levels should be measured, and if needed, adrenal reserves should be checked by conducting low-dose ACTH test. Although there are many references for threshold of cortisol response to low-dose ACTH test, for term newborns, levels of 20 μg/dL and above should be accepted as normal response (13). For patients with adrenal insufficiency, physiological replacement should be started. Moreover, in case of stressful conditions, the dose of steroid should be increased 2-3 times, because it has been shown that antenatal steroids can change the response to neonatal stress (14) . Low-dose ACTH test should be repeated at specified intervals and, as soon as adrenal response returns to normal, replacement therapy should be slowly tapered and stopped.
